MedTrace Logo

Treatment Strategy for Adult Congenital Biliary Dilation

NCT07336576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 234

Last updated 2026-01-13

No results posted yet for this study

Summary

The management of congenital biliary dilations (CBDs), including choledochal cysts, represents one of the most challenging areas in hepatobiliary surgery due to their potential implications for long-term morbidity and malignant transformation. While CBDs have a relatively low incidence in Western populations (1/150,000-1/100,000), the prevalence is notably higher in Asian countries (1/1,000), making it a significant global health concern. Although complete surgical resection remains the standard of care, the optimal extent of resection and reconstruction strategy, particularly for complex disease patterns, continues to be debated. To address these challenges, the current study proposes a novel surgery-oriented classification system for adult CBD based on the analysis of 234 consecutive cases.

Conditions

  • Congenital Biliary Dilation

Interventions

PROCEDURE

hepatectomy、liver transplantation、hepaticojejunostomy

resection of the diseased bile duct, elimination of secondary lesions, and restoration of biliary-enteric continuity.

Sponsors & Collaborators

  • Beijing Tsinghua Chang Gung Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-06-01
Completion
2025-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07336576 on ClinicalTrials.gov